Hollencrest Capital Management Cuts Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Hollencrest Capital Management cut its UnitedHealth Group position by 98.7% in the second quarter, selling 134,103 shares and retaining 1,746 shares valued at approximately $726,000.
• Analysts remain broadly positive on UNH, with a consensus rating of “Moderate Buy” and an average price target of $456.56; UBS raised its target to $490.
• UnitedHealth reported quarterly EPS of $6.38, exceeding estimates of $4.94, and announced a quarterly dividend of $2.32, equivalent to an annualized yield of about 2.4%.

Hollencrest Capital Management trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 98.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,746 shares of the healthcare conglomerate's stock after selling 134,103 shares during the quarter. Hollencrest Capital Management's holdings in UnitedHealth Group were worth $726,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $4,376,167,000. Corient Private Wealth LP purchased a new stake in shares of UnitedHealth Group during the second quarter worth $245,516,000. Legal & General Group Plc purchased a new position in UnitedHealth Group in the second quarter valued at $2,444,928,000. Jupiter Topco LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $2,019,844,000. Finally, BlackRock Inc. boosted its stake in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

Several analysts recently weighed in on UNH shares. Cantor Fitzgerald reaffirmed an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, June 11th. UBS Group raised their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a "buy" rating in a report on Friday, July 17th. Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Zacks Research upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 13th. Finally, Piper Sandler set a $477.00 price objective on UnitedHealth Group in a report on Thursday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $456.56.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.19% of the company's stock.

UnitedHealth Group Trading Down 0.3%

NYSE UNH opened at $393.99 on Friday. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The company has a market capitalization of $353.64 billion, a price-to-earnings ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The firm's fifty day moving average price is $413.28 and its 200 day moving average price is $360.11.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter last year, the company posted $4.08 earnings per share. The business's quarterly revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's payout ratio is currently 59.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source